PRESS RELEASE published on 06/09/2026 at 13:00, 1 month 26 days ago DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference DBV Technologies to participate in 1-on-1 investor meetings at Goldman Sachs Annual Global Healthcare Conference. CEO unavailable for fireside chat. Company focused on developing food allergy treatments with VIASKIN patch technology Investor Meetings DBV Technologies Food Allergies Goldman Sachs Conference VIASKIN Patch Technology
PRESS RELEASE published on 06/09/2026 at 13:00, 1 month 26 days ago DBV Technologies révise sa participation à la 47ème conférence annuelle Global Healthcare organisée par Goldman Sachs DBV Technologies annonce sa participation à la 47ème conférence annuelle Global Healthcare organisée par Goldman Sachs à Miami, Floride. La direction tiendra des entretiens avec les investisseurs Goldman Sachs Conférence Annuelle Global Healthcare DBV Technologies Technologie VIASKIN
BRIEF published on 06/08/2026 at 22:40, 1 month 27 days ago DBV Technologies dévoile des données prometteuses sur les traitements contre l'allergie aux arachides Étude VITESSE Technologies DBV Patch Aux Arachides VIASKIN Traitement De L'allergie Aux Arachides Étude THRIVE
BRIEF published on 06/08/2026 at 22:40, 1 month 27 days ago DBV Technologies Unveils Promising Data on Peanut Allergy Treatments DBV Technologies Viaskin Peanut Patch Peanut Allergy Treatment VITESSE Study THRIVE Study
BRIEF published on 06/08/2026 at 22:40, 1 month 27 days ago DBV Technologies : Nouvelles avancées dans le traitement de l'allergie à l'arachide Immunothérapie DBV Technologies Viaskin Peanut Allergie Arachide Étude VITESSE
BRIEF published on 06/08/2026 at 22:40, 1 month 27 days ago DBV Technologies: New advances in the treatment of peanut allergy Immunotherapy DBV Technologies Viaskin Peanut Peanut Allergy SPEED Study
PRESS RELEASE published on 06/08/2026 at 22:35, 1 month 27 days ago DBV Technologies présente de nouvelles données positives issues de l’étude de phase 3 VITESSE, et un aperçu de l’étude THRIVE récemment initiée à l’occasion du Congrès de l’EAACI 2026 DBV Technologies présente de nouvelles données positives de l'étude de phase 3 VITESSE sur le patch VIASKIN Peanut pour les allergies à l'arachide, avec un aperçu de l'étude THRIVE au congrès EAACI 2026 DBV Technologies Allergies Alimentaires Étude VITESSE Patch Viaskin Peanut Étude THRIVE
PRESS RELEASE published on 06/08/2026 at 22:35, 1 month 27 days ago DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026 DBV Technologies to present new positive data from VITESSE study and preview THRIVE study at EAACI Congress 2026. VIASKIN Peanut Patch efficacy in peanut-allergic children with atopic comorbidities DBV Technologies Viaskin Peanut Patch VITESSE Study THRIVE Study EAACI Congress 2026
BRIEF published on 06/08/2026 at 09:37, 1 month 27 days ago DBV Technologies : J.P. Morgan Chase & Co. franchit à la baisse le seuil de 10% Droits De Vote Franchissement De Seuil DBV Technologies Capital Actions J.P. Morgan Chase
BRIEF published on 06/08/2026 at 09:37, 1 month 27 days ago DBV Technologies: JP Morgan Chase & Co. falls below the 10% threshold Share Capital Voting Rights Threshold Crossing DBV Technologies JP Morgan Chase
Published on 08/06/2026 at 03:35, 3 hours 29 minutes ago Tunkillia Upgrade Drilling – 39,000m Phase 2 Complete Targeting JORC Resource Classification Upgrades; PFS Underway
Published on 08/06/2026 at 01:40, 5 hours 24 minutes ago Taranis Identifies a Hydrothermally Altered, Sulfide-Bearing Intrusive Stock Associated with Historic Gold-Silver Occurrence and Connected to Thor
Published on 08/05/2026 at 23:40, 7 hours 24 minutes ago Galantas Gold Secures Key Permitting Approvals for Andacollo Gold Project
Published on 08/05/2026 at 23:10, 7 hours 54 minutes ago Ur-Energy Announces Date for Second Quarter 2026 Results and Conference Call and Webcast
Published on 08/05/2026 at 23:01, 8 hours 3 minutes ago Full Circle Lithium Announces Extension of Current Private Placement
Published on 08/06/2026 at 06:40, 24 minutes ago Galenica maintains its track record of consistent growth
Published on 08/06/2026 at 06:30, 33 minutes ago Ad hoc announcement pursuant to Art. 53 LR News Release
Published on 08/06/2026 at 06:26, 38 minutes ago EQS-Adhoc: Deutsche Telekom AG: Deutsche Telekom increases 2026 share buy-back program by up to 3 billion euros
Published on 08/05/2026 at 23:23, 7 hours 40 minutes ago EQS-Adhoc: Enapter AG: Agreement with Patrimonium to discharge corporate bond liabilities of around EUR 26 million; realignment to an asset-light business model; capital measure planned
Published on 08/05/2026 at 18:00, 13 hours 4 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2026
Published on 08/05/2026 at 18:00, 13 hours 4 minutes ago Information concerning the total number of voting rights and shares in the share capital as of July 31, 2026
Published on 08/05/2026 at 17:49, 13 hours 14 minutes ago Mersen : nombre d'actions et de droits de vote au 31 juillet 2026
Published on 08/05/2026 at 17:49, 13 hours 14 minutes ago Mersen: Number of shares and voting rights as of July 31, 2026
Published on 08/05/2026 at 17:45, 13 hours 19 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL